Clinical Trial Update: Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/Phase 3 clinical trial is evaluating ozone therapy for chemotherapy-induced peripheral neuropathy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Ozone Therapy

Snippet

Sponsor: Bernardino Clavo, MD, PhD | Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia | Phase 2, Phase 3 | Status: RECRUITING